Back to search results

Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)

Abroad (travel likely)Recruiting

Conditions

Esophageal Neoplasms · Esophagectomy · Brain Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Patricia Abraham)
    Contact: Principal Investigator (Wayne Hofstetter)

  • Universitair ziekenhuis Gent, Ghent, Belgium

    Contact: Study coordinator (Inge Vandenbroucke)
    Contact: Principal Investigator (Elke Van Daele)

  • Centre Hospitalier régional Universitaire de Lille, Lille, France

    Contact: Study coordinator (Sébastien Degisors)
    Contact: Principal Investigator (Guillaume Piessen, PhD)

  • Saint James Hospital, Dublin, Ireland

    Contact: Study coordinator (Noel E Donlon)
    Contact: Principal Investigator (John Reynolds)

  • Amsterdam UMC, Amsterdam, Netherlands

    Contact: Study coordinator (Daan Voeten)
    Contact: Principal Investigator (Mark Van Berge Henegouwen, PhD)

  • Zuyderland MC, Heerlen, Netherlands

    Contact: Study coordinator (Julie Van Den Bosch, MD)
    Contact: Principal Investigator (Meindert Sosef, PhD)

  • Erasmus MC, Rotterdam, Netherlands

    Contact: Study coordinator (x gao)
    Contact: Principal Investigator (Bas Wijnhoven, PhD)

  • Karolinska Institutet, Stockholm, Sweden

    Contact: Study coordinator (Biying Huang)
    Contact: Principal Investigator (Magnus Nilsson, PhD)
Study leads

  • Lieven P Depypere, PhD

    Principal Investigator

    UZ Leuven

View source on ClinicalTrials.gov(opens in a new tab)